November 12, 2020

12 Nov 20 | AU | Celltrion | The TGA approves Celltrion's subcutaneous "biobetter" infliximab product Remsima in auto-injection pen and PFS presentations. This is the first subcut infliximab product to be approved in Australia.

26 Oct 20 | All | Samsung Bioepis | S...

October 7, 2020

08 Oct 2020 | All | Celltrion | Korea Biomedical Review reports Celltrion has received approval for Ph III trials of CT-P39 (proposed omalizumab biosimilar).

14 Jul 2020 | All | Celltrion | In an interview with the Centre for Biosimilars, Celltrion's head of marketing,...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags